Natixis Advisors, L.P. Astrazeneca PLC Transaction History

Natixis Advisors, L.P.

  • $68.5 Billion
  • Q3 2025

A detailed history of Natixis Advisors, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Natixis Advisors, L.P. holds 2,100,390 shares of AZN stock, worth $188 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,100,390
Previous 1,837,925 14.28%
Holding current value
$188 Million
Previous $128 Million 25.47%
% of portfolio
0.24%
Previous 0.2%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$68.72 - $82.11 $18 Million - $21.6 Million
262,465 Added 14.28%
2,100,390 $161 Million
Q2 2025

Aug 13, 2025
SELL
$64.87 - $75.0 $25.8 Million - $29.9 Million
-398,086 Reduced 17.8%
1,837,925 $128 Million
Q1 2025

May 08, 2025
BUY
$65.37 - $77.96 $11.5 Million - $13.7 Million
175,813 Added 8.53%
2,236,011 $164 Million
Q4 2024

Feb 10, 2025
BUY
$63.2 - $79.58 $6.28 Million - $7.91 Million
99,383 Added 5.07%
2,060,198 $135 Million
Q3 2024

Nov 06, 2024
BUY
$76.67 - $87.62 $8.98 Million - $10.3 Million
117,162 Added 6.35%
1,960,815 $153 Million
Q2 2024

Aug 01, 2024
BUY
$66.81 - $80.83 $18.6 Million - $22.5 Million
277,946 Added 17.75%
1,843,653 $144 Million
Q1 2024

Apr 25, 2024
BUY
$61.03 - $69.57 $19.2 Million - $21.9 Million
315,089 Added 25.19%
1,565,707 $106 Million
Q4 2023

Feb 06, 2024
BUY
$61.89 - $69.28 $4.85 Million - $5.42 Million
78,286 Added 6.68%
1,250,618 $84.2 Million
Q3 2023

Nov 13, 2023
BUY
$64.85 - $71.7 $2.44 Million - $2.7 Million
37,668 Added 3.32%
1,172,332 $79.4 Million
Q2 2023

Aug 15, 2023
BUY
$69.91 - $75.81 $9.25 Million - $10 Million
132,265 Added 13.19%
1,134,664 $81.2 Million
Q1 2023

May 11, 2023
BUY
$63.15 - $71.6 $7.53 Million - $8.54 Million
119,228 Added 13.5%
1,002,399 $69.6 Million
Q4 2022

Jan 27, 2023
SELL
$54.21 - $70.44 $1.18 Million - $1.53 Million
-21,730 Reduced 2.4%
883,171 $59.9 Million
Q3 2022

Nov 14, 2022
BUY
$53.02 - $135.75 $14.2 Million - $36.2 Million
266,986 Added 41.85%
904,901 $49.6 Million
Q2 2022

Aug 12, 2022
SELL
$59.26 - $71.14 $134,994 - $162,056
-2,278 Reduced 0.36%
637,915 $42.1 Million
Q1 2022

May 12, 2022
BUY
$55.72 - $67.12 $2.67 Million - $3.21 Million
47,865 Added 8.08%
640,193 $42.5 Million
Q4 2021

Feb 08, 2022
BUY
$54.02 - $63.83 $1,836 - $2,170
34 Added 0.01%
592,328 $34.5 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $5.59 Million - $6.12 Million
100,623 Added 20.47%
592,294 $35.6 Million
Q2 2021

Aug 12, 2021
BUY
$48.42 - $60.18 $3.52 Million - $4.38 Million
72,770 Added 17.37%
491,671 $29.5 Million
Q1 2021

May 05, 2021
BUY
$47.16 - $54.44 $2.65 Million - $3.06 Million
56,281 Added 15.52%
418,901 $20.8 Million
Q4 2020

Feb 12, 2021
SELL
$48.52 - $58.02 $375,496 - $449,016
-7,739 Reduced 2.09%
362,620 $18.1 Million
Q3 2020

Nov 12, 2020
SELL
$53.07 - $61.1 $1.03 Million - $1.19 Million
-19,499 Reduced 5.0%
370,359 $20.3 Million
Q2 2020

Aug 11, 2020
SELL
$43.1 - $55.31 $44,177 - $56,692
-1,025 Reduced 0.26%
389,858 $20.6 Million
Q1 2020

Apr 27, 2020
SELL
$37.79 - $51.33 $679,124 - $922,451
-17,971 Reduced 4.4%
390,883 $17.5 Million
Q4 2019

Feb 10, 2020
SELL
$42.46 - $50.46 $3.29 Million - $3.91 Million
-77,431 Reduced 15.92%
408,854 $20.4 Million
Q3 2019

Nov 12, 2019
SELL
$40.12 - $45.47 $5.22 Million - $5.92 Million
-130,215 Reduced 21.12%
486,285 $21.7 Million
Q2 2019

Aug 12, 2019
BUY
$37.28 - $41.68 $335,184 - $374,744
8,991 Added 1.48%
616,500 $25.4 Million
Q1 2019

May 15, 2019
SELL
$35.49 - $43.02 $402,314 - $487,674
-11,336 Reduced 1.83%
607,509 $24.6 Million
Q4 2018

Feb 13, 2019
BUY
$36.86 - $41.49 $1.41 Million - $1.59 Million
38,248 Added 6.59%
618,845 $23.5 Million
Q3 2018

Nov 13, 2018
BUY
$34.76 - $39.72 $280,478 - $320,500
8,069 Added 1.41%
580,597 $23 Million
Q2 2018

Aug 14, 2018
BUY
$34.55 - $37.05 $170,469 - $182,804
4,934 Added 0.87%
572,528 $0
Q1 2018

May 10, 2018
BUY
$32.97 - $36.63 $829,327 - $921,391
25,154 Added 4.64%
567,594 $19.8 Million
Q4 2017

Feb 14, 2018
BUY
$32.09 - $34.78 $871,949 - $945,042
27,172 Added 5.27%
542,440 $18.8 Million
Q3 2017

Nov 14, 2017
BUY
$28.96 - $34.0 $14.9 Million - $17.5 Million
515,268
515,268 $17.5 Million

Others Institutions Holding AZN

# of Institutions
1,501
Shares Held
500M
Call Options Held
5.64M
Put Options Held
3.2M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email